TriSalus Life Sciences, Inc.
TLSI • NASDAQ
TriSalus Life Sciences, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Mary T. Szela, with a market cap of $278.2M.
Market Cap$278.2M
CEOMary T. Szela
CountryUnited States of America
Healthcare
Medical - Devices
Next EarningsMay 21, 2026 · In 4 weeksBefore Market Open · Q1 2026
Financials
TriSalus Life Sciences, Inc. FAQ
Common questions about TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. is scheduled to report earnings for Q1 2026 on May 21, 2026 before market open. Analysts estimate revenue of $10.4M.